Compare Tata Nifty MidSmall Healthcare Index Fund vs UTI Healthcare Fund
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.12 | 2.28 |
NAV | ₹12.12 | ₹269.31 |
Fund Started | 08 Apr 2024 | 01 Aug 2005 |
Fund Size | ₹158.82 Cr | ₹1101.63 Cr |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.12
2.28
NAV
₹12.12
₹269.31
Fund Started
08 Apr 2024
01 Aug 2005
Fund Size
₹158.82 Cr
₹1101.63 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 1% if redeemed within 30 days.
1 Year | 0.08% | -3.06% |
3 Year | - | 22.21% |
5 Year | - | 13.89% |
1 Year
0.08%
-3.06%
3 Year
-
22.21%
5 Year
-
13.89%
Equity | 100.06% | 99.40% |
Cash | -0.06% | 0.59% |
Equity
100.06%
99.40%
Cash
-0.06%
0.59%
Top 10 Holdings |
|
|
Top 10 Holdings
Lupin Ltd. | 9.51% |
Fortis Healthcare Ltd. | 8.56% |
Laurus Labs Ltd. | 8.00% |
Aurobindo Pharma Ltd. | 6.15% |
Alkem Laboratories Ltd. | 5.99% |
Glenmark Pharmaceuticals Ltd. | 5.70% |
Mankind Pharma Ltd. | 4.62% |
Biocon Ltd. | 4.40% |
Ipca Laboratories Ltd. | 3.67% |
Abbott India Ltd. | 2.82% |
Sun Pharmaceutical Industries Ltd. | 9.37% |
Ajanta Pharma Ltd. | 7.16% |
Lupin Ltd. | 5.65% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Gland Pharma Ltd. | 3.60% |
Procter & Gamble Health Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.46% |
Cipla Ltd. | 3.43% |
Alkem Laboratories Ltd. | 3.40% |
Apollo Hospitals Enterprise Ltd. | 3.39% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 08 Apr 2024 | 01 Aug 2005 |
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
08 Apr 2024
01 Aug 2005